Protected: The VESL Wall Issue #9 is now out! We take a look at new triglyceride data with the antisense therapy olezarsen, a systematic review and meta-analysis of CV outcomes in patients with HoFH, and the association between adherence to the Portfolio cholesterol-reducing diet and mortality in a cohort of Chinese patients

This content is password protected. To view it please enter your password below: